ritanserin has been researched along with Hyperoxia in 1 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.
Excerpt | Relevance | Reference |
---|---|---|
"To elucidate the role of serotonin in the maintenance of normal breathing and upper airway (UA) patency in obesity, we studied the effects of systemic administration of ritanserin, a serotonin (5-HT) 2A and 2C receptor antagonist, on ventilation (V E) during room air breathing and during hypoxic (10% O2) and hypercapnic (4% CO2) ventilatory challenges in awake young (6-8 wk) and older (7-8 mo) obese and lean Zucker (Z) rats." | 3.71 | Serotonergic modulation of ventilation and upper airway stability in obese Zucker rats. ( Farkas, GA; Krasney, JA; Lee, SD; Magalang, UJ; Nakano, H, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakano, H | 1 |
Magalang, UJ | 1 |
Lee, SD | 1 |
Krasney, JA | 1 |
Farkas, GA | 1 |
1 other study available for ritanserin and Hyperoxia
Article | Year |
---|---|
Serotonergic modulation of ventilation and upper airway stability in obese Zucker rats.
Topics: Age Factors; Analysis of Variance; Animals; Hypercapnia; Hyperoxia; Linear Models; Obesity; Plethysm | 2001 |